A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination

International Journal of Infectious Diseases

Volumn 14, Issue 6, 2010, Pages

  Zhang, Li ^a,b   Xu, Aiqiang ^a   Yan, Bingyu ^a   Song, Lizhi ^a   Li, Manshi ^a   Xiao, Zuokui ^a   Xu, Qing ^a   Li, Liming ^c  

^a Shandong Center for Disease Control and Prevention   (China)

^b SHANDONG UNIVERSITY   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Prevalence; Universal infant hepatitis B vaccination; Vaccination coverage

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CHINA; CONTROLLED STUDY; DEMOGRAPHY; DISEASE MARKER; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFANT; INFECTION CONTROL; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; TREATMENT DURATION; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; MASS VACCINATION; PROGRAM EVALUATION; SEROEPIDEMIOLOGIC STUDIES;

EID: 77952241647     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2009.08.005     Document Type: Article

References (22)

1. Beasley R.P., Hwang L.Y., and Lin C.C. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet 2 (1981) 1129-1133
2. Li Yu. An epidemiological study on viral hepatitis in China. Zhonghua Weishengwuxue He Mianyixue Zhazhi 1986;(Suppl):1-15.
3. Dai ZC, Qi GM. [Viral hepatitis seroepidemiological survey in Chinese population, 1992-1995 (part one)] (in Chinese). Beijing, China: Science and Technical Documents Publishing House; 1997, p. 39-59.
4. Chinese Center for Disease Control and Prevention. Results from a nationwide hepatitis B seroepidemiological survey in China, 2006. Available at: http://www.chinacdc.net.cn/n272442/n272530/n3246177/23316.html (accessed April 2008).
5. Dai Z.C., and Qi G.M. [Viral hepatitis seroepidemiological survey in Chinese population, 1992-1995 (part two)] (in Chinese) (1997), Science and Technical Documents Publishing House, Beijing, China p. 105-14
6. Population Census Office of Shandong Province. [Tabulation on the 2000 population census of Shandong Province] (in Chinese) (2002), China Statistics Press, Beijing, China p. 1041-4
7. Centers for Disease Control and Prevention (CDC). Progress in hepatitis B prevention through universal infant vaccination-China, 1997-2006. MMWR Morb Mortal Wkly Rep 56 (2007) 441-445
8. Ni Y.H., Huang L.M., Chang M.H., Yen C.J., Lu C.Y., You S.L., et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 132 (2007) 1287-1293
9. Hayashi J., Kajiyama W., Noguchi A., Ikematsu H., Nomura H., Nakashima K., et al. Marked decrease of hepatitis B virus infection among children in Okinawa, Japan. Int J Epidemiol 19 (1990) 1083-1085
10. Hsu H.M., Lu C.F., Lee S.C., Liu S.R., and Chen D.S. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis 179 (1999) 367-370
11. Zanetti A.R., Romano L., Zappa A., and Velati C. Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supply. J Clin Virol 36 Suppl 1 (2006) S51-S55
12. Dentinger C.M., McMahon B.J., Butler J.C., Dunaway C.E., Zanis C.L., Bulkow L.R., et al. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J 24 (2005) 786-792
13. Yuen M.F., Lim W.L., Chan A.O., Wong D.K., Sum S.S., and Lai C.L. 18-year following-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children. Clin Gastroenterol Hepatol 2 (2004) 941-995
14. Liao S.S., Li R.C., Li H., Yang J.Y., Zenf X.J., Gong J., et al. Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year following-up study among Chinese children. Vaccine 17 (1999) 2661-2666
15. El Sawy I.H., and Mohamed O.N. Long-term immunogenicity and efficacy of a recombinant hepatitis B vaccine in Egyptian children. East Mediterr Health J 5 (1999) 922-932
16. Goh K.T., Oon C.J., Heng B.H., and Lim G.K. Long-term immunogenicity and efficacy of a reduced dose of plasma-based hepatitis B vaccine in young adults. Bull World Health Organ 73 (1995) 523-527
17. Zanetti A.R., Mariano A., Romano L., D'Amelio R., Chironna M., Coppola R.C., et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 366 (2005) 1379-1384
18. Gabbuti A., Romano L., Blanc P., Meacci F., Amendola A., Mele A., et al. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine 25 (2007) 3129-3132
19. Lin Y.C., Chang M.H., Ni Y.H., Hsu H.Y., and Chen D.S. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis 187 (2003) 134-138
20. Su F.H., Chen J.D., Cheng S.H., Sung K.Y., Jeng J.J., and Chu F.Y. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme. J Viral Hepat 15 (2008) 14-19
21. Avazova D., Kurbanov F., Tanaka Y., Sugiyama M., Radchenko I., Ruziev D., et al. Hepatitis B virus transmission pattern and vaccination efficiency in Uzbekistan. J Med Virol 80 (2008) 217-224
22. Hsu H.Y., Chang M.H., Ni Y.H., and Chen H.L. Survey of hepatitis B surface variant infection in children 15 years after nationwide vaccination program in Taiwan. Gut 53 (2004) 1499-1503